Concierge urological diagnostics · London
Saturation biopsies of the prostate, extensive transperineal sampling for men with persistently rising PSA and negative prior biopsy.
Saturation biopsy of the prostate is an extensive transperineal biopsy technique — 30-40+ cores under general anaesthetic — for men with persistently rising PSA and prior negative TRUS biopsies, or for detailed cancer mapping before focal therapy.
Key facts
- 01
Extensive transperineal biopsy
A saturation biopsy is an extensive transperineal prostate sampling technique — not a routine TRUS.
- 02
General anaesthetic day-case
Performed under general anaesthetic as a day-case procedure in a private theatre.
- 03
30–40+ cores
Systematic template sampling of 30–40+ cores across the entire gland, mapped to sector.
- 04
Higher detection than TRUS
Detects significant prostate cancer missed by prior transrectal (TRUS) biopsy.
- 05
Foundation for focal therapy
Provides the per-sector map that focal HIFU or cryotherapy planning depends on.
- 06
Complements mpMRI
Correlates every sector against multiparametric MRI — imaging and pathology together.
The problem
A negative TRUS biopsy isn’t always the answer.
Standard transrectal biopsy systematically undersamples the anterior and apical prostate. When PSA keeps rising after a negative TRUS, or when focal therapy is on the table, the answer is a full transperineal saturation map — not another round of the same test.
-
Rising PSA, negative TRUS?
We arrange a saturation biopsy to sample the parts of the gland TRUS misses.
-
Planning focal therapy?
The per-sector map is the foundation focal HIFU or cryotherapy planning depends on.
-
Discordant mpMRI?
A PI-RADS 4/5 lesion with a negative sector needs re-read and template resampling.
The diagnostic pathway
From consultation to MDT plan — what happens, in order.
One consultant urologist from first message to plan, with the multi-disciplinary team behind every decision.
Phase 1 · Before your procedure
Consultation, imaging, anaesthetic review
Phase 2 · Day-case theatre
General anaesthetic, template biopsy
Phase 3 · After
Pathology, MDT, written plan
- 01
Before
Urology consultation
Consultant urologist reviews PSA trend, prior biopsies, symptoms, family history and comorbidity.
- 02
Before
mpMRI review
Multiparametric prostate MRI is re-read against PI-RADS and mapped to sectors before theatre.
- 03
Before
General anaesthetic assessment
Pre-operative anaesthetic review — fitness, medication, day-case planning.
- 04
Theatre
Transperineal saturation biopsy
30–40+ template cores taken through the perineum under general anaesthetic — no rectal entry.
- 05
After
Pathology per core
Uropathology reports each core individually — Gleason grade, ISUP group, cancer length.
- 06
After
MDT review
Uro-oncology multi-disciplinary team combines imaging, pathology and clinical picture.
- 07
After
Structured plan
A written plan — surveillance, focal therapy, radical treatment or observation — with next steps.
Typical end-to-end: 2–3 weeks. Urgent cases: 7–10 days.
What it shows
What the sector-by-sector map reveals.
A saturation biopsy answers questions a TRUS cannot — where the disease is, how much of it there is, and whether the gland is a candidate for focal therapy.
-
Per-core Gleason grade
Every core reported individually with Gleason score and ISUP grade group.
-
Per-core cancer length
Millimetre length of cancer in each core — a key driver of significance.
-
Anterior tumour detection
Reaches anterior and apical zones that transrectal biopsy systematically undersamples.
-
Bilateral disease pattern
Maps whether disease is unilateral, bilateral, unifocal or multifocal.
-
Tumour volume estimation
Approximates disease burden — foundation for treatment intensity decisions.
-
Radiological–pathological concordance
Correlates mpMRI PI-RADS lesions against the histology of each sector.
-
Suitability for focal therapy
The sector map is what focal HIFU, cryotherapy or electroporation planning is built on.
-
Red flag: unexpected Gleason 8+ — urgent MDT
Any core with Gleason 8+ triggers urgent multi-disciplinary team review the same week.
Treatment options
What the biopsy result opens up.
The saturation map defines the treatment shortlist. The MDT chooses — not the biopsy alone.
-
Active surveillance
For low-grade unifocal disease — structured PSA, mpMRI and repeat biopsy protocol rather than immediate treatment.
-
Focal HIFU / cryotherapy
Targeted ablation of a mapped tumour focus — organ-sparing, with continence and potency largely preserved.
-
Radical prostatectomy
Robot-assisted removal of the prostate — for organ-confined disease where cure is the goal.
-
External beam radiotherapy
Image-guided IMRT or SBRT — an alternative to surgery for organ-confined disease.
-
Brachytherapy
Low-dose-rate seeds or high-dose-rate temporary implants — selected localised disease.
-
Androgen deprivation therapy
Hormonal treatment, alone or alongside radiotherapy, in higher-risk or advanced disease.
-
Structured urology + oncology follow-up
Combined follow-up pathway with PSA, imaging and clinical review on a defined cadence.
-
Multi-disciplinary team review
Every plan is set by urology, oncology, radiology and pathology together — never a single voice.
Our vetted London network
A small panel of consultants, we picked them.
Uro-oncology consultants across central London. Not listed publicly — introductions are made privately, once we understand your case.
Selection criteria
How we choose every surgeon in our network.
-
Consultant urological surgeons with a focal-therapy sub-specialty
-
Dedicated uropathology reporting — per-core Gleason and ISUP grading
-
Multiparametric prostate MRI read against PI-RADS by a uro-radiologist
-
Weekly uro-oncology MDT with radiology, oncology and pathology present
Red flags
When to call, when to go to A&E.
A saturation biopsy is a well-tolerated day-case, but there are specific findings and post-procedure symptoms that change the timeline.
-
Unexpected Gleason 8+
High-grade histology on any core triggers urgent MDT and staging within the week.
-
Bilateral high-volume disease
Extensive disease in both lobes usually redirects the plan away from focal therapy.
-
Extraprostatic extension
Disease breaching the prostate capsule on imaging or histology changes treatment intent.
-
Post-biopsy sepsis
Fever, rigors or systemic symptoms after biopsy — same-day A&E, not the private clinic.
-
Post-biopsy urinary retention
Inability to pass urine after biopsy — same-day catheterisation via A&E or the operating team.
-
Post-biopsy rectal injury
Rare in transperineal biopsy — any significant rectal bleeding needs urgent review.
-
Anaesthetic complication
Any post-anaesthetic concern — chest pain, breathlessness, prolonged drowsiness — is a 999 call.
-
Rising PSA post-biopsy
A rising PSA on surveillance after a negative saturation biopsy warrants re-imaging and MDT discussion.
-
Discordant mpMRI–pathology
A PI-RADS 4/5 lesion with a negative sector needs re-read, not reassurance.
Reading your report
A saturation biopsy report can look intimidating. It isn’t.
Whatever the finding, the pathology report keeps to the same four parts.
A quiet reminder
The report is written for the MDT, not for you — and that’s normal.
If you would like us to talk you through it before your follow-up, just ask.
- 01 Header
Indication and prior investigations
Your details, PSA trend, prior TRUS results and the mpMRI referenced for the case.
- 02 Technique
Template, cores and anaesthetic
Which template was used, how many cores were taken, and the anaesthetic and antibiotic protocol.
- 03 Findings
Per-core Gleason, length and sector
Each core reported individually — Gleason score, ISUP grade, cancer length and sector location.
- 04 Impression
The MDT-ready summary: read this first
Overall grade group, laterality, imaging concordance and the concrete next step — read this first.
Recognised by major UK insurers
Cover depends on your policy and clinic; we confirm with your insurer before booking.
Frequently asked
Everything we get asked about saturation biopsy.
Quick answers on how it differs from TRUS, who needs it, the risks, recovery, and what happens if cancer is found.
-
What is a saturation biopsy of the prostate?
A saturation biopsy is an extensive transperineal prostate biopsy — typically 30 to 40 or more cores taken through the perineum under general anaesthetic, using a systematic template that samples the entire gland including anterior and apical zones that transrectal biopsy tends to miss.
-
Who needs a saturation biopsy?
It is used for men with a persistently rising PSA and one or more prior negative TRUS biopsies, and for detailed cancer mapping before focal therapy such as HIFU or cryotherapy. Your urologist and the multi-disciplinary team decide, alongside your mpMRI.
-
How is it different from a standard TRUS biopsy?
A standard TRUS biopsy is done through the rectum, takes 10–12 cores, and is performed under local anaesthetic. A saturation biopsy is done through the perineum, takes 30–40+ cores on a systematic template, and requires general anaesthetic — with higher cancer detection and near-zero sepsis risk.
-
What are the risks?
The main risks are urinary retention, perineal bruising, transient haematuria and haematospermia, and the general risks of anaesthesia. Sepsis is very uncommon because the biopsy avoids the rectum. Rectal injury is rare.
-
How long is recovery?
A day-case procedure. Most men go home the same afternoon and are back to office work within 2–3 days. Blood in the semen can persist for several weeks and is expected — not a complication.
-
What happens if cancer is found?
Your case goes to the uro-oncology multi-disciplinary team. The written plan sets out options — active surveillance, focal therapy, radical prostatectomy, radiotherapy or hormonal treatment — chosen for your grade, volume, imaging and preferences.
Sources
Guidelines this guide is built on.
- NICE. Prostate cancer: diagnosis and management (NG131).
- European Association of Urology. Prostate cancer guidelines.
- British Association of Urological Surgeons. Prostate biopsy guidance.
- Focal Therapy Society. Consensus on focal therapy for prostate cancer.
Last reviewed 2026-07-30 · Next review 2027-07-30 · 6 min read
Related tests
Looking for a different test?
-
Prostate biopsy
The standard transperineal or TRUS biopsy for a first-line diagnosis.
Learn more -
Prostate cancer prostate mapping
Detailed prostate mapping for treatment planning after diagnosis.
Learn more -
Private prostate health check
PSA, examination and mpMRI as a structured screening package.
Learn more -
All tests
Browse every test and procedure we arrange.
Learn more -
Prostate Enlargement BPH
Related condition guide.
Learn more -
Kidney Disease CKD
Related condition guide.
Learn more -
Cystectomy
Related treatment option.
Learn more -
Cystoplasty
Related treatment option.
Learn more
In practice, in London
How saturation biopsies prostate tends to unfold when you go private
With saturation biopsies prostate, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. The NHS route for saturation biopsies prostate is thorough, but the queue is real. Most patients we speak with have been told to expect anywhere from a handful of weeks to several months, depending on their local trust and how the referral is graded. Going private in London usually collapses that window to a matter of days — often the same week if the diary allows. It isn’t about jumping a queue so much as buying time back while you still have the flexibility to plan around it.
In practice, a private saturation biopsies prostate appointment in London means a named consultant, a proper hour in the room (or the equivalent on a video call), and a report you can actually read. Most of the imaging suites and endoscopy units we use sit within a mile of Harley Street or in Chelsea and Fulham, and turnaround on findings is measured in days, not weeks. For saturation biopsies prostate specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.
The value of going through a concierge for saturation biopsies prostate isn’t access — anyone with an insurer or a credit card can get a private appointment in London. The value is knowing which consultant reads this particular presentation best, which unit turns reports around fastest, and which pathway won’t hit a dead end if the findings point somewhere unexpected.
Nearby in the library